Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Charles P Hannon, Susan M Goodman, Matthew S Austin, Adolph Yates, Gordon Guyatt, Vinay K Aggarwal, Joshua F Baker, Phyllis Bass, Delamo Isaac Bekele, Danielle Dass, Hassan M K Ghomrawi, David S Jevsevar, C Kent Kwoh, Claudette M Lajam, Charis F Meng, Larry W Moreland, Linda I Suleiman, Jesse Wolfstadt, Kimberly Bartosiak, Nicholas A Bedard, Jason L Blevins, Anna Cohen-Rosenblum, P Maxwell Courtney, Ruth Fernandez-Ruiz, Elizabeth B Gausden, Nilasha Ghosh, Lauren K King, Alexa Simon Meara, Bella Mehta, Reza Mirza, Adam J Rana, Nancy Sullivan, Marat Turgunbaev, Katherine D Wysham, Kevin Yip, Linda Yue, Michael G Zywiel, Linda Russell, Amy S Turner, Jasvinder A Singh
OBJECTIVE: To develop evidence-based consensus recommendations for the optimal timing of hip and knee arthroplasty to improve patient-important outcomes including, but not limited to, pain, function, infection, hospitalization, and death at 1 year for patients with symptomatic and radiographic moderate-to-severe osteoarthritis or advanced symptomatic osteonecrosis with secondary arthritis of the hip or knee who have previously attempted nonoperative therapy, and for whom nonoperative therapy was ineffective, and who have chosen to undergo elective hip or knee arthroplasty (collectively referred to as TJA)...
September 25, 2023: Arthritis & Rheumatology
#2
JOURNAL ARTICLE
Merav Birk-Bachar, Hadar Cohen, Efrat Sofrin-Drucker, Nesia Kropach-Gilad, Naama Orenstein, Gabriel Lidzbarsky, Liora Kornreich, Rotem Tal, Gil Amarilyo, Yoel Levinsky, Meirav Sokolov, Eyal Raveh, Motti Gerlic, Liora Harel
OBJECTIVE: Cryopyrin-associated periodic syndromes (CAPS), also known as NLRP3-associated auto-inflammatory diseases, are a spectrum of rare auto-inflammatory diseases caused by gain-of-function variants in the NLRP3 gene, resulting in inflammasome hyper-activation and dysregulated release of Interleukin-1β (IL-1β). Many patients with CAPS develop progressive sensorineural hearing loss (SNHL) due to cochlear auto-inflammation, which may be the sole manifestation in rare cases...
September 22, 2023: Arthritis & Rheumatology
#3
LETTER
Lars Alfredsson, Lars Klareskog, Anna Karin Hedström
No abstract text is available yet for this article.
September 21, 2023: Arthritis & Rheumatology
#4
LETTER
Chien-Yu Lin, Hsuan Chang, Tzu-Chiao Kung, James Cheng-Chung Wei
No abstract text is available yet for this article.
September 21, 2023: Arthritis & Rheumatology
#5
JOURNAL ARTICLE
Xinyi Zhu, Yutong Zhang, Zihang Yin, Zhizhong Ye, Yuting Qin, Zhaorui Cheng, Yiwei Shen, Zhihua Yin, Jianyang Ma, Yuanjia Tang, Huihua Ding, Ya Guo, Guojun Hou, Nan Shen
OBJECTIVE: The diminished expression of miR-146a in SLE contributes to the aberrant activation of the interferon pathway. Despite its significance, the underlying mechanism driving this reduced expression remains elusive. Considering the integral role of enhancers in steering gene expression, our study seeks to pinpoint the SLE-affected enhancers responsible for modulating miR-146a expression. Additionally, we aim to elucidate the mechanisms by which these enhancers influence miR-146a's contribution to the activation of interferon pathway...
September 20, 2023: Arthritis & Rheumatology
#6
JOURNAL ARTICLE
Jeungchan Lee, Asimina Lazaridou, Myrella Paschali, Marco L Loggia, Michael P Berry, Dan-Mikael Ellingsen, Kylie Isenburg, Alessandra Anzolin, Arvina Grahl, Ajay D Wasan, Vitaly Napadow, Robert R Edwards
OBJECTIVE: Fibromyalgia (FM) is characterized by pervasive pain-related symptomatology and high levels of negative affect. Mind-body treatments such as cognitive-behavioral therapy (CBT) appear to foster improvement in FM via reductions in pain-related catastrophizing, a set of negative, pain-amplifying cognitive and emotional processes. However, the neural underpinnings of CBT's catastrophizing-reducing effects remain uncertain. This randomized, controlled, mechanistic trial was designed to assess CBT's effects on pain catastrophizing and its underlying brain circuitry...
September 20, 2023: Arthritis & Rheumatology
#7
LETTER
Bonnie L Bermas, Irene Blanco, Ashira D Blazer, Megan Eb Clowse, Cuoghi Edens, Rosalind Ramsey-Goldman, Greer Donley, Leslie Pierce, Catherine Wright, Mehret Birru Talabi
No abstract text is available yet for this article.
September 14, 2023: Arthritis & Rheumatology
#8
LETTER
Maria De Santis, Antonio Tonutti, Francesca Motta, Stefano Rodolfi, Natasa Isailovic, Carlo Selmi
No abstract text is available yet for this article.
September 14, 2023: Arthritis & Rheumatology
#9
JOURNAL ARTICLE
Francisca C Venegas, Ricardo Sánchez-Rodríguez, Roberto Luisetto, Roberta Angioni, Antonella Viola, Marcella Canton
OBJECTIVE: Calcium pyrophosphate (CPP) crystal deposition in the joints is associated with a heterogeneous set of debilitating syndromes characterized by inflammation and pain, for which no effective therapies are currently available. As we found that the mitochondrial enzyme monoamine oxidase B (MAO-B) plays a fundamental role in promoting inflammatory pathways, this study aims at assessing the efficacy of two clinical-grade inhibitors (iMAO-Bs) in preclinical models of this disease, to pave the way for a novel treatment...
September 11, 2023: Arthritis & Rheumatology
#10
JOURNAL ARTICLE
Keith Colaco, Ker-Ai Lee, Shadi Akhtari, Raz Winer, Vinod Chandran, Paula Harvey, Richard J Cook, Vincent Piguet, Dafna D Gladman, Lihi Eder
OBJECTIVE: To address sub-optimal cardiovascular risk prediction in patients with psoriatic disease (PsD), we developed and internally validated a 5-year disease-specific cardiovascular risk prediction model. METHODS: We analyzed data from a prospective cohort of participants with PsD without a history of cardiovascular events. Traditional cardiovascular risk factors and PsD-related measures of disease activity were considered as potential predictors. The study outcome included non-fatal and fatal cardiovascular events...
September 11, 2023: Arthritis & Rheumatology
#11
LETTER
Ranjeet Singh Mahla
No abstract text is available yet for this article.
September 10, 2023: Arthritis & Rheumatology
#12
JOURNAL ARTICLE
Karin Magnusson, Aleksandra Turkiewicz, Martin Rydén, Martin Englund
AIM: To compare the genetic contribution to osteoarthritis (OA) vs other rheumatic/musculoskeletal diseases (RMDs) in the same population, and 2) to explore the role for any shared genetics between OA and other RMDs. METHODS: In 59 970 Swedish twins aged 35 years or older, we estimated the heritability (the variance explained by genetic factors) to OA in peripheral joints, back and neck pain, shoulder pain (adhesive capsulitis, impingement syndrome, etc), rheumatoid arthritis (RA), spondyloarthritis and psoriatic arthritis (SpA/PSA), myalgia and osteoporosis diagnosed in specialist and inpatient care...
September 10, 2023: Arthritis & Rheumatology
#13
JOURNAL ARTICLE
Shigemi Morishita, Ken-Ei Sada
No abstract text is available yet for this article.
September 10, 2023: Arthritis & Rheumatology
#14
JOURNAL ARTICLE
Marco Gattorno, Laura Obici, Inmaculada Calvo Penadés, Tilmann Kallinich, Susanne Benseler, Elise Dekker, Jérémy Lévy, Fabrizio De Benedetti, Helen Lachmann
OBJECTIVES: To assess efficacy, safety, and tolerability of canakinumab in patients with tumor necrosis factor receptor-associated periodic syndrome (TRAPS) during a 72-week long-term, open-label extension of the CLUSTER study. METHODS: Patients received open-label canakinumab 150 or 300 mg, either every 4 weeks (q4w) or every 8 weeks, with up-titration permitted following on-treatment flares (maximum dose: 300 mg q4w). Efficacy assessments included physician global assessment (PGA) of disease activity, number of flares, and serum C-reactive protein (CRP) and serum amyloid A protein (SAA) levels...
September 5, 2023: Arthritis & Rheumatology
#15
JOURNAL ARTICLE
Maria Suñol, Jon Dudley, Michael F Payne, Han Tong, Tracy V Ting, Susmita Kashikar-Zuck, Robert C Coghill, Marina López-Solà
OBJECTIVES: Juvenile-onset fibromyalgia (JFM) is a paradigmatic chronic pain condition for which the underlying neurobiological substrates are poorly understood. This study examined for the first time data-driven resting-state functional connectivity (rsFC) alterations in 37 female adolescents with JFM compared with 43 healthy female adolescents, and identified associations with bodily pain. METHODS: Whole-brain voxel-wise rsFC alterations were assessed using the intrinsic connectivity contrast, a measure of node centrality at each voxel, and seed-based analyses for interpretability...
September 4, 2023: Arthritis & Rheumatology
#16
JOURNAL ARTICLE
Riccardo Papa, Roberta Caorsi, Stefano Volpi, Marco Gattorno
No abstract text is available yet for this article.
September 3, 2023: Arthritis & Rheumatology
#17
EDITORIAL
Richard Bucala, Daniel H Solomon
No abstract text is available yet for this article.
September 1, 2023: Arthritis & Rheumatology
#18
LETTER
April M Jorge, Emma Materne, Baijun Zhou, Karen Costenbader, Yuqing Zhang, Hyon K Choi
No abstract text is available yet for this article.
August 31, 2023: Arthritis & Rheumatology
#19
LETTER
Mia Rodziewicz, Sarah Dyball, Sheilla Achieng, Silke R Brix, Ian N Bruce, Ben Parker
No abstract text is available yet for this article.
August 31, 2023: Arthritis & Rheumatology
#20
JOURNAL ARTICLE
Leoni Schlupp, Emmaline Prinz, Gabriella Dyson, Montana Barrett, Vladislav Izda, Christopher M Dunn, Matlock A Jeffries
OBJECTIVE: Female mice have reduced osteoarthritis (OA) in surgical models. The objective of the current study was to evaluate a sex-linked gut microbiome in the pathogenesis of OA. METHODS: We induced OA via destabilization of the medial meniscus (DMM) surgery in adult male and female C57BL6/J mice with and without opposite-sex microbiome transplantation. Eight weeks later, animals were euthanized and OA severity, synovitis, and osteophyte scores determined. Serum lipopolysaccharide (LPS) was measured chromogenically, and serum cytokines were quantified via multiplex immunoassay...
August 31, 2023: Arthritis & Rheumatology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
